Submissions from 2025
Collaborating across sectors in service of open science, precision oncology, and patients: an overview of the AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) Biopharma Collaborative (BPC), A Acebedo, Brian D. Piening, and See full list of authors in comments
Census Tract Rurality, Predominant Race and Ethnicity, and Distance to Lung Cancer Screening Facilities : An Ecological Study., Solmaz Amiri, Candice L. Wilshire, Clemma Jacobsen Muller, Cole Allick, Allison C Welch, Gary Ferguson, Dedra Buchwald, and Jed A Gorden
Amivantamab Plus Lazertinib in Patients With EGFR-Mutant NSCLC After Progression on Osimertinib and Platinum-Based Chemotherapy: Results From CHRYSALIS-2 Cohort A., Benjamin Besse, Koichi Goto, Yongsheng Wang, Se-Hoon Lee, Melina E Marmarelis, Yuichiro Ohe, Reyes Bernabe Caro, Dong-Wan Kim, Jong-Seok Lee, Sophie Cousin, Eiki Ichihara, Yongsheng Li, Luis Paz-Ares, Akira Ono, Rachel E Sanborn, Naohiro Watanabe, Maria Jose de Miguel, Carole Helissey, Catherine A Shu, Alexander I Spira, Pascale Tomasini, James Chih-Hsin Yang, Yiping Zhang, Enriqueta Felip, Frank Griesinger, Saiama N Waqar, Antonio Calles, Joel W Neal, Christina S Baik, Pasi A Jänne, S Martin Shreeve, Joshua C Curtin, Bharvin Patel, Michael Gormley, Xuesong Lyu, Jun Chen, Pei-Ling Chu, Janine Mahoney, Leonardo Trani, Joshua M Bauml, Meena Thayu, Roland E Knoblauch, and Byoung Chul Cho
A multi-institutional retrospective cohort of adult-onset medulloblastoma in the modern era., Alipi V Bonm, Michael S Rutenberg, Kate E Therkelsen, John Herbst, Anurag Sanaf, Marissa A Sherwood, John Y Rhee, Tresa M McGranahan, Patrick J Cimino, L Nicolas Gonzalez Castro, Derek S Tsang, Matthias A Karajannis, Seema Nagpal, Robert J Amdur, Helen Shih, Jason Barber, and Lynne P Taylor
Evaluation of the Toxicity and Outcomes of the Combination of Midostaurin and CLAG-M in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML): A Multicenter Retrospective Analysis., Ashley Chen, Grace Baek, Kathryn Russell, Carole Shaw, Megan Othus, Jonathan Cohen, Shannon Palmer, Jack Rasmussen, Joseph Bubalo, Tenzin Tsomo, Tenley Schwarz, Swathi Namburi, and Anna Halpern
Importance of Surgical Margins in Patients with Early-Stage Merkel Cell Carcinoma., Arthur W Cowman, Kristel Lourdault, Douglas Hanes, Sean Nassoiy, Paul Shin, Tyler Aguilar, Melanie Goldfarb, and Richard Essner
Surgical Management of Thick Primary Cutaneous Melanoma in the US., Arthur W Cowman, Kristel Lourdault, Douglas Hanes, Jessica Weiss, Sean Nassoiy, Melanie Goldfarb, and Richard Essner
Checkpoint Immunotherapy for Melanoma - Offering Hope for Cure., Brendan Curti
A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies., Matthew S Davids, Danielle M Brander, Yesid Alvarado-Valero, Catherine S Diefenbach, Daniel N Egan, Shira N Dinner, Nathalie Javidi-Sharifi, Monzr M Al Malki, Kebede H Begna, Vijaya Raj Bhatt, Sameem Abedin, Rachel J Cook, Mary C Collins, Carly Roleder, Edward C Dominguez, Prabhu Rajagopalan, Sandra E Wiley, Richard G Ghalie, and Alexey V Danilov
OLIG2 mediates a rare targetable stem cell fate transition in sonic hedgehog medulloblastoma., Kinjal Desai, Siyi Wanggou, Erika Luis, Heather Whetstone, Chunying Yu, Robert J Vanner, Hayden J Selvadurai, Lilian Lee, Jinchu Vijay, Julia E Jaramillo, Jerry Fan, Paul Guilhamon, Michelle Kushida, Xuejun Li, Gregory Stein, Santosh Kesari, Benjamin D Simons, Xi Huang, and Peter B Dirks
Classification of non-TCGA cancer samples to TCGA molecular subtypes using compact feature sets., Kyle Ellrott, Christopher K Wong, Christina Yau, Mauro A A Castro, Jordan A Lee, Brian J Karlberg, Jasleen K Grewal, Vincenzo Lagani, Bahar Tercan, Verena Friedl, Toshinori Hinoue, Vladislav Uzunangelov, Lindsay Westlake, Xavier Loinaz, Ina Felau, Peggy I Wang, Anab Kemal, Samantha J Caesar-Johnson, Ilya Shmulevich, Alexander J Lazar, Ioannis Tsamardinos, Katherine A Hoadley, A Gordon Robertson, Theo A Knijnenburg, Christopher C Benz, Joshua M Stuart, Jean C Zenklusen, Andrew D Cherniack, and Peter W Laird
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer., Charles E Geyer, Michael Untch, Chiun-Sheng Huang, Max S Mano, Eleftherios P Mamounas, Norman Wolmark, Priya Rastogi, Andreas Schneeweiss, Andres Redondo, Hans H Fischer, Véronique D'Hondt, Alison Conlin, Valentina Guarneri, Irene L Wapnir, Christian Jackisch, Claudia Arce-Salinas, Peter A Fasching, Michael P DiGiovanna, John P Crown, Pia Wuelfing, Zhimin Shao, Elena Rota Caremoli, Hervé R Bonnefoi, Bryan T Hennessy, Ljiljana Stamatovic, Hugo Castro-Salguero, Adam M Brufsky, Adam Knott, Asna Siddiqui, Chiara Lambertini, Thomas Boulet, Beatrice Nyawira, Eleonora Restuccia, Sibylle Loibl, and KATHERINE Study Group
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial., Armin Ghobadi, Veronika Bachanova, Krish Patel, Jae H Park, Ian Flinn, Peter A Riedell, Carlos Bachier, Catherine S Diefenbach, Carol Wong, Cara Bickers, Lilly Wong, Deepa Patel, Jode Goodridge, Matthew Denholt, Bahram Valamehr, Rebecca L Elstrom, and Paolo Strati
A Multisite Demonstration of Shared Access to Older Adults' Patient Portals., Kelly T Gleason, Catherine M DesRoches, Mingche M J Wu, Danielle Peereboom, Vadim Dukhanin, Timothy W Farrell, Matthew J Gonzales, Saloni Sharma, Supriya G Mohile, Sara Epstein, Mark A Supiano, Marianne C Parshley, David L Roth, Jennifer L Wolff, and Shared Access Project Team
Pilot Study of Plasma miRNA Signature Panel for Differentiating Single vs Multiglandular Parathyroid Disease., Melanie Goldfarb, Matias A Bustos, Jamie Moon, Katherine Jackson, Frederick R Singer, and Dave S B Hoon
Continuing De-escalation Trends: Is Adjuvant Radioactive Iodine Administration Truly Needed for Papillary Thyroid Carcinoma with Limited Cervical Disease?, Melanie Goldfarb and Nicholas Ullman
Human Epidermal Growth Factor Receptor 2 Alterations and Prognostic Implications in All Subtypes of Breast Cancers., Arielle L Heeke, Andrew Elliott, Kaitlyn O'Keefe, Chad Livasy, James T Symanowski, Meghan R Steiner, Irene M Kang, Dave S B Hoon, Philip Walker, George W Sledge, Milan Radovich, Paula R Pohlmann, Sandra M Swain, and Antoinette R Tan
Neoadjuvant clinical trials in adults with newly diagnosed high-grade glioma: A systematic review., Tiffany M Juarez, Jaya M Gill, Boris R Minev, Akanksha Sharma, and Santosh Kesari
Neoadjuvant clinical trials in adults with newly diagnosed high-grade glioma: A systematic review., Tiffany M Juarez, Jaya M Gill, Boris R Minev, Akanksha Sharma, and Santosh Kesari
Evaluating Tumor Tissue Modified Viral (TTMV)-HPV DNA for the Early Detection of Anal Squamous Cell Carcinoma Recurrence., Rafi Kabarriti, Shane Lloyd, James Jabalee, Catherine Del Vecchio Fitz, Randa Tao, Tyler Slater, Corbin Jacobs, Sean Inocencio, Michael Rutenberg, Chance Matthiesen, Kasha Neff, Gene-Fu Liu, Tiffany M Juarez, and Stanley L Liauw
Commentary: Molecular responses in pig heart to human xenotransplantation unveiled by longitudinal multi-omic profiling., Brendan J Keating, Eloi Schmauch, Michael P Snyder, Jennifer D Motter, and Brian D. Piening
Machine Learning Model Predictors of Intrapleural Tissue Plasminogen Activator and DNase Failure in Pleural Infection: A Multicenter Study., Danai Khemasuwan, Candice Wilshire, Chakravarthy Reddy, Christopher Gilbert, Jed Gorden, Akshu Balwan, Trinidad M Sanchez, Billie Bixby, Jeffrey S Sorensen, and Samira Shojaee
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve, Xiuning Le, Jyoti D Patel, Elaine Shum, Christina Baik, Rachel E Sanborn, Catherine A Shu, Chul Kim, Mary Jo Fidler, Richard Hall, Yasir Y Elamin, Janet Tu, George Blumenschein, Jianjun Zhang, Don Gibbons, Carl Gay, Nisha A Mohindra, Young Chae, Yanis Boumber, Joshua Sabari, Rafael Santana-Davila, Shane Rogosin, Benjamin Herzberg, Ben Creelan, Bruna Pellini, Tawee Tanvetyanon, Simon Heeke, Mike Hernandez, Jhanelle E Gray, Andreas Saltos, and John V Heymach
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial., Juanita Lopez, Thomas Powles, Fadi Braiteh, Lillian L Siu, Patricia LoRusso, Claire F Friedman, Ani S Balmanoukian, Michael Gordon, Jeffrey Yachnin, Sylvie Rottey, Ioannis Karydis, George A Fisher, Marcus Schmidt, Martin Schuler, Ryan J Sullivan, Howard A Burris, Vladimir Galvao, Brian S Henick, Luc Dirix, Dirk Jaeger, Patrick A Ott, Kit Man Wong, Guy Jerusalem, Aglaia Schiza, Lawrence Fong, Neeltje Steeghs, Rom Leidner, Achim Rittmeyer, Scott A Laurie, Eelke Gort, Raid Aljumaily, Ignacio Melero, Rachel L Sabado, Ina Rhee, Michael R Mancuso, Lars Muller, Gregg D Fine, Mahesh Yadav, Leesun Kim, Vincent J P Leveque, Alberto Robert, Martine Darwish, Ting Qi, Jiawen Zhu, Jingbin Zhang, Patrick Twomey, Gautham K Rao, Donald W Low, Chris Petry, Amy A Lo, Jill M Schartner, Lélia Delamarre, Ira Mellman, Martin Löwer, Felicitas Müller, Evelyna Derhovanessian, Andrea Cortini, Luisa Manning, Daniel Maurus, Sebastian Brachtendorf, Verena Lörks, Tana Omokoko, Eva Godehardt, Dirk Becker, Christine Hawner, Christine Wallrapp, Christian Albrecht, Christoph Kröner, Arbel D Tadmor, Jan Diekmann, Mathias Vormehr, Anette Jork, Anna Paruzynski, Maren Lang, Jonathon Blake, Oliver Hennig, Andreas N Kuhn, Ugur Sahin, Özlem Türeci, and D Ross Camidge
In Regard to Aly et al., Join Y Luh
Implementation of a lisocabtagene maraleucel chimeric antigen receptor T-cell therapy outpatient monitoring program: Multicenter nursing/advanced practice provider perspectives., Nicole McEntee, Jacqueline Manago, ChiaChun Lu, and Lucy Holmes
Long-Term Outcomes of Radiation Monotherapy Versus Combined Radiation Monotherapy + Hormone Therapy in Low-Risk Early-Stage Breast Cancer Patients 70 Years or Older After Breast-Conserving Surgery., Astrid D Morris, Douglas Hanes, and Henry G Kaplan
State of the art endocrine treatments for patients diagnosed with endometrial cancer in 2025., Fernanda Musa, Kathleen N Moore, Vivek Podder, and Brian M Slomovitz
Comparative microRNA signatures based on liquid biopsy to identify lymph node metastasis in T1 colorectal cancer patients undergoing upfront surgery or endoscopic resection., Kazuaki Okamoto, Hiroaki Nozawa, Tsuyoshi Ozawa, Yoko Yamamoto, Yuichiro Yokoyama, Shigenobu Emoto, Koji Murono, Kazuhito Sasaki, Mitsuhiro Fujishiro, and Soichiro Ishihara
Analysis of Endoscope-Assisted Retrosigmoid Approach versus Modified Transjugular Approach for Microvascular Decompression of the Facial Nerve: A Comparative Cadaveric Study., Mehrdad Pahlevani, Felipe Sfeir, Fan Zhao, Kayla Lanker, Alex Corlin, Regin Jay Mallari, Gregory Lekovic, and Garni Barkhoudarian
Head and Neck Cancer Research Training Program Associated with Academic Success for Trainees., Aanish Puri, Andrew C Elton, Beverly R Wuertz, and Frank G Ondrey
Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With, Kanwal Pratap Singh Raghav, Katherine A Guthrie, Benjamin Tan, Crystal S Denlinger, Marwan Fakih, Michael J Overman, N Arvind Dasari, Larry R Corum, Lee G Hicks, Mital S Patel, Benjamin T Esparaz, Syed M Kazmi, Nitya Alluri, Sarah Colby, Sepideh Gholami, Philip J Gold, E Gabriela Chiorean, Scott Kopetz, Howard S Hochster, and Philip A Philip
Adoption of Single-Port Robotic Partial Nephrectomy Increases Utilization of the Retroperitoneal Approach: A Report from the Single-Port Advanced Research Consortium., Michael Raver, Mutahar Ahmed, Kennedy E Okhawere, Indu Saini, Ruchir Chaturvedi, Milan Patel, Ruben Sauer Calvo, Nicolas A Soputro, Roxana Ramos, Mubashir Billah, Simone Crivellaro, Ahmed M Mansour, Jihad Kaouk, Nirmish Singla, James Porter, Ronney Abaza, Akshay Bhandari, Ashok K Hemal, Phillip M Pierorazio, Benjamin I Chung, Craig G Rogers, Reza Mehrazin, Ketan Badani, and Michael Stifelman
American Association of Neurological Surgeons/Congress of the Neurological Surgeons Section on Tumors Guidelines: Assessing Their Impact on Brain Tumor Clinical Practice., Faith C Robertson, Brian V Nahed, Garni Barkhoudarian, Anand Veeravagu, David Berg, Steven Kalkanis, Jeffrey J Olson, and Isabelle M Germano
Abstract P004: Mapping the tumor-sentinel node immune migratome demonstrates a key role for CCR7+ dendritic cells in the successful response to immunoradiotherapy, Robert Saddawi-Konefka, Shawn M. Jensen, Bernard A Fox, Richard Bryan Bell, and See full list of authors in comments
Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer., Jacob M Sands, Stéphane Champiat, Horst-Dieter Hummel, Kelly G Paulson, Hossein Borghaei, Jean Bustamante Alvarez, David P Carbone, Jennifer W Carlisle, Noura J Choudhury, Jeffrey M Clarke, Shirish M Gadgeel, Hiroki Izumi, Alejandro Navarro, Sally C M Lau, Philip E Lammers, Shuang Huang, Ali Hamidi, Sujoy Mukherjee, and Taofeek K Owonikoko
The improved prognosis of FLT3-internal tandem duplication but not tyrosine kinase domain mutations in acute myeloid leukemia in the era of targeted therapy: a real-world study using large-scale electronic health record data, Matthew Schwede, Gladys Rodriguez, Vanessa E Kennedy, Solomon Henry, Douglas Wood, Gabriel N Mannis, Ravindra Majeti, Jonathan H Chen, Eran Bendavid, and Tian Yi Zhang
Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial., Nirav N Shah, Michael Wang, Lindsey E Roeker, Krish Patel, Jennifer A Woyach, William G Wierda, Chaitra S Ujjani, Toby A Eyre, Pier Luigi Zinzani, Alvaro J Alencar, Paolo Ghia, Nicole Lamanna, Marc S Hoffmann, Manish R Patel, Ian Flinn, James N Gerson, Shuo Ma, Catherine C Coombs, Chan Y Cheah, Ewa Lech-Maranda, Bita Fakhri, Won Seog Kim, Minal A Barve, Jonathon B Cohen, Wojciech Jurczak, Talha Munir, Meghan C Thompson, Donald E Tsai, Katherine Bao, Nicholas A Cangemi, Jennifer F Kherani, Richard A Walgren, Hongmei Han, Amy S Ruppert, and Jennifer R Brown
Correction: Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia., Jeff P Sharman, Miklos Egyed, Wojciech Jurczak, Alan Skarbnik, John M Pagel, Ian W Flinn, Manali Kamdar, Talha Munir, Renata Walewska, Gillian Corbett, Laura Maria Fogliatto, Yair Herishanu, Versha Banerji, Steven Coutre, George Follows, Patricia Walker, Karin Karlsson, Paolo Ghia, Ann Janssens, Florence Cymbalista, Jennifer A Woyach, Emmanuelle Ferrant, William G Wierda, Veerendra Munugalavadla, Ting Yu, Min Hui Wang, and John C Byrd
A Microfluidic, Multi-Antibody Cell Capture Method to Evaluate Tumor Cells in Cerebrospinal Fluid in Patients With Suspected Leptomeningeal Metastases., Nathan T Sweed, Hao-Ching Hsiao, Barbara Blouw, Tony J Pircher, Deanna Fisher, Katrina Rose Naluz, Julie Ann Mayer, Michael C Dugan, Akanksha Sharma, Jose Carrillo, and Santosh Kesari
Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapy., Kengo Tanigawa and William L Redmond
Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing., Janis M Taube, Joel C Sunshine, Michael Angelo, Guray Akturk, Margaret Eminizer, Logan L Engle, Cláudia S Ferreira, Sacha Gnjatic, Benjamin Green, Shirley Greenbaum, Noah F Greenwald, Cyrus V Hedvat, Travis J Hollmann, Daniel Jiménez-Sánchez, Konstanty Korski, Ana Lako, Edwin R Parra, Marlon C Rebelatto, David L Rimm, Scott J Rodig, Jamie Rodriguez-Canales, Jeffrey S Roskes, Kurt A Schalper, Emanuel Schenck, Keith E Steele, Michael J Surace, Alexander S Szalay, Michael T Tetzlaff, Ignacio I Wistuba, Jennifer H Yearley, and Carlo Bifulco
Outcomes of CD19 CAR T in Transformed Indolent Lymphoma Compared to De Novo Aggressive Large B-Cell Lymphoma., Swetha Kambhampati Thiruvengadam, Reid Merryman, Yan Wang, Charles Gaulin, Evandro Bezerra, Timothy Voorhees, Madhav R Seshadri, Ayo Falade, Alma Habib, Amy A Ayers, Megumi Bailey, Annette Brown, Neil Bailey, Krish Patel, Charalambos B Andreadis, Adam S Kittai, Caron Jacobson, Joycelynne Palmer, Stephen J Forman, Loretta Nastoupil, and Lihua E Budde
Outcomes of CD19 CAR T in Transformed Indolent Lymphoma Compared to De Novo Aggressive Large B-Cell Lymphoma., Swetha Kambhampati Thiruvengadam, Reid Merryman, Yan Wang, Charles Gaulin, Evandro Bezerra, Timothy Voorhees, Madhav R Seshadri, Ayo Falade, Alma Habib, Amy A Ayers, Megumi Bailey, Annette Brown, Neil Bailey, Krish Patel, Charalambos B Andreadis, Adam S Kittai, Caron Jacobson, Joycelynne Palmer, Stephen J Forman, Loretta Nastoupil, and Lihua E Budde
Characteristics of patients with liver tumors deemed ineligible for enrollment on Children's Oncology Group trial AHEP1531: An opportunity to expand inclusion criteria and improve outcome., Angela Trobaugh-Lotrario, Allison F O'Neill, Katelyn A Belmonte, Marcio H Malogolowkin, Greg M Tiao, and James I Geller
The first international experience with histotripsy: a safety analysis of 230 cases., Chase J Wehrle, Kevin Burns, Evan Ong, Allison Couillard, Neehar D Parikh, Elaine Caoili, JaeKeun Kim, Federico Aucejo, Andrea Schlegel, Emily Knott, Paul Laeseke, J Philip Boudreaux, Philipp von Breitenbuch, Mikhail Silk, Mohamed Alassas, Andrew Guzowski, Brian Fuller, Erica Knavel Koepsel, Brock Hewitt, Mishal Mendiratta-Lala, and David C H Kwon
Durability of response of UGN-101: Longitudinal follow up of multicenter study., Solomon L Woldu, Daniel Igel, Brett Johnson, Katie S Murray, Hiroko Miyagi, Wade Sexton, Isamu Tachibana, Hristos Kaimakliotis, Joseph Jacob, Rian Dickstein, Jennifer M Linehan, Alan Nieder, Marc A Bjurlin, Daniel Heidenberg, Mitchell Humphreys, Saum Ghodoussipour, Marcus L Quek, Michael O'Donnell, Brian H Eisner, Surena F Matin, Adam S Feldman, and Yair Lotan
Identification and validation of a T cell receptor targeting KRAS G12V in HLA-A*11:01 pancreatic cancer patients., Xiongfei Xu, Shiwei Guo, Haihui Gu, Zhanshan Cha, Xiaohan Shi, Xiaoyi Yin, Huan Wang, Suizhi Gao, Bo Li, Lingyu Zhu, Wei Jing, Kailian Zheng, Zhuo Shao, Peng Cheng, Chunhong Zheng, Yi-Ping Shih, Yunguang Li, Baohua Qian, Dong Gao, Eric Tran, and Gang Jin
Machine-learning diagnostics of breast cancer using piRNA biomarkers., Amy R Zhao, Valentina L Kouznetsova, Santosh Kesari, and Igor F Tsigelny
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes., Nicholas A Zorko, Allison Makovec, Andrew Elliott, Samuel Kellen, John R Lozada, Ali T Arafa, Martin Felices, Madison Shackelford, Pedro Barata, Yousef Zakharia, Vivek Narayan, Mark N Stein, Kevin K Zarrabi, Akash Patniak, Mehmet A Bilen, Milan Radovich, George Sledge, Wafik S El-Deiry, Elisabeth I Heath, Dave S B Hoon, Chadi Nabhan, Jeffrey S Miller, Justin H Hwang, and Emmanuel S Antonarakis
Submissions from 2024
Type B Lactic Acidosis: A Very Rare but Fatal Complication of Gastrointestinal Solid Tumor., Fuad I Abaleka, Genanew Bedanie, Diego Olavarria Bernal, Selome F Yewedalsew, and Tasur Seen
Clinical and Multiomic Features Differentiate Young Black and White Breast Cancer Cohorts Derived by Machine Learning Approaches., Kawther Abdilleh, Boris Aguilar, and George Acquaah-Mensah
Combining a complex cancer vaccine with anti-PD-1 and DGK inhibitor Improves therapeutic efficacy and may augment anti-cancer memory development, E Adwani, Brian Fox, and See full list of authors in comments
Nuclear Protein in Testis Carcinoma of the Orbit., Chip Agarwal, Anand Bhatt, and Frank P K Hsu
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)., Rahul Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Dorff, Leonard Appleman, Douglas Weckstein, Akash Patnaik, Alan Bryce, Daniel Shevrin, James Mohler, Daniel Anderson, Arpit Rao, Scott Tagawa, Alan Tan, Susan Halabi, Katharine Dooley, Patrick O'Brien, Ronald Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, EORTC-55994 Study Group, and Brendan Curti (EORTC-55994 Study Group)
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery., Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, A Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debu Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown-Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica Stringer-Reasor, Sarah Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle Melisko, Jane Perlmutter, Hope S Rugo, W Fraser Symmans, Laura J Van't Veer, Douglas Yee, Donald A Berry, and Laura J Esserman
A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers., Alain P Algazi, James Moon, Christopher D Lao, Bartosz Chmielowski, Kari L Kendra, Karl D Lewis, Rene Gonzalez, Kevin Kim, John E Godwin, Brendan D. Curti, Michaella Latkovic-Taber, Shirley H Lomeli, Brandon T Gufford, Philip O Scumpia, Roger S Lo, Megan Othus, and Antoni Ribas
Pathologic Features of Esophageal and Gastric Malignancies., Sanaa Al-Nattah, Eduard Matkovic, Michael Schwalbe, and Kristina A Matkowskyj
The doc versus the bot: A pilot study to assess the quality and accuracy of physician and chatbot responses to clinical questions in gynecologic oncology., Mary Katherine Anastasio, Pamela Peters, Jonathan Foote, Alexander Melamed, Susan C Modesitt, Fernanda Musa, Emma Rossi, Benjamin B Albright, Laura J Havrilesky, and Haley A Moss
Using Machine Learning and miRNA for the Diagnosis of Esophageal Cancer., Vishnu A Aravind, Valentina L Kouznetsova, Santosh Kesari, and Igor F Tsigelny
Drug delivery in leptomeningeal disease: Navigating barriers and beyond., Numair Arshad, Nupur Biswas, Jaya Gill, Santosh Kesari, and Shashaanka Ashili
Tumor Regression Following Engineered Polyomavirus-Specific T Cell Therapy in Immune Checkpoint Inhibitor-Refractory Merkel Cell Carcinoma., Yuta Asano, Joshua Veatch, Megan McAfee, Jakob Bakhtiari, Bo Lee, Lauren Martin, Shihong Zhang, Francesco Mazziotta, Kelly G Paulson, Thomas M Schmitt, Ariunnaa Munkbhat, Cecilia Young, Brandon Seaton, Daniel Hunter, Nick Horst, Marcus Lindberg, Natalie Miller, Matt Stone, Jason Bielas, David Koelle, Valentin Voillet, Raphael Gottardo, Ted Gooley, Shannon Oda, Philip D Greenberg, Paul Nghiem, and Aude G Chapuis
A pilot study of nintedanib in molecularly selected patients with advanced non-small cell lung cancer., Christine Auberle, Feng Gao, Mark Sloan, Daniel Morgensztern, Linda Winkler, Jeffrey P Ward, Siddhartha Devarakonda, Timothy P Rearden, Ramaswamy Govindan, and Saiama N Waqar
Biological and prognostic relevance of epigenetic regulatory genes in high-grade gliomas., Sonikpreet Aulakh, Joanne Xiu, Andrew Hinton, Sourat Darabi, Michael J Demeure, Soma Sengupta, Santosh Kesari, David M Ashley, Ashley Love Sumrall, Michael J Glantz, and David Spetzler
Pomalidomide/Daratumumab/Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Overall Survival From MM-014., Nizar J Bahlis, Christy Samaras, Donna Reece, Michael Sebag, Jeffrey Matous, Jesús G Berdeja, Jesse Shustik, Gary J Schiller, Siddhartha Ganguly, Kevin Song, Christopher S Seet, Mirelis Acosta-Rivera, Michael Bar, Donald Quick, Gustavo Fonseca, Hongjuan Liu, Christian Gentili, Pavit Singh, and David Siegel
Segmentation of pre- and posttreatment diffuse glioma tissue subregions including resection cavities., Saif Baig, Igor Vidic, George M Mastorakos, Robert X Smith, Nathan White, Suzie Bash, Anders M Dale, Carrie R McDonald, Thomas Beaumont, Tyler M Seibert, Jona Hattangadi-Gluth, Santosh Kesari, Nikdokht Farid, and Jeffrey D Rudie
A novel small molecule Enpp1 inhibitor improves tumor control following radiation therapy by targeting stromal Enpp1 expression., Jason R Baird, Alejandro F Alice, Roland Saito, Qingqing Chai, Minhua Han, Cindy Ng, Stephanie Han, Beth Fernandez, Sarah Ledoux, Johannes Grosse, Alan J Korman, Megan Potuznik, Venkatesh Rajamanickam, Brady Bernard, Marka R Crittenden, and Michael J. Gough
Genomic and transcriptomic landscape of HER2-low breast cancer., Rani Bansal, Tolulope Adeyelu, Andrew Elliott, Phillip Walker, Matias A Bustos, Estelamari Rodriguez, Melissa K Accordino, Jane Meisel, Margaret E Gatti-Mays, Emily Hsu, Kate Lathrop, Virginia Kaklamani, Matthew Oberley, George Sledge, Sarah L Sammons, and Stephanie L Graff
Endonasal surgery high-risk carotid injury timeout checklist: implementation, institutional protocol and experience., Garni Barkhoudarian, Mehrdad Pahlevani, Seshaan Ratnam, Regin Jay Mallari, Chester Griffiths, and Daniel F Kelly
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk., Daniel R Barnes, Jonathan P Tyrer, Joe Dennis, Goska Leslie, Manjeet K Bolla, Michael Lush, Amber M Aeilts, Kristiina Aittomäki, Nadine Andrieu, Irene L Andrulis, Hoda Anton-Culver, Adalgeir Arason, Banu K Arun, Judith Balmaña, Elisa V Bandera, Rosa B Barkardottir, Lieke P V Berger, Amy Berrington de Gonzalez, Pascaline Berthet, Katarzyna Białkowska, Line Bjørge, Amie M Blanco, Marinus J Blok, Kristie A Bobolis, Natalia V Bogdanova, James D Brenton, Henriett Butz, Saundra S Buys, Maria A Caligo, Ian Campbell, Carmen Castillo, Kathleen B M Claes, Sarah V Colonna, Linda S Cook, Mary B Daly, Agnieszka Dansonka-Mieszkowska, Miguel de la Hoya, Anna deFazio, Allison DePersia, Yuan Chun Ding, Susan M Domchek, Thilo Dörk, Zakaria Einbeigi, Christoph Engel, D Gareth Evans, Lenka Foretova, Renée T Fortner, Florentia Fostira, Maria Cristina Foti, Eitan Friedman, Megan N Frone, Patricia A Ganz, Aleksandra Gentry-Maharaj, Gord Glendon, Andrew K Godwin, Anna González-Neira, Mark H Greene, Jacek Gronwald, Aliana Guerrieri-Gonzaga, Ute Hamann, Thomas V O Hansen, Holly R Harris, Jan Hauke, Florian Heitz, Frans B L Hogervorst, Maartje J Hooning, John L Hopper, Chad D Huff, David G Huntsman, Evgeny N Imyanitov, Louise Izatt, Anna Jakubowska, Paul A James, Ramunas Janavicius, Esther M John, Siddhartha Kar, Beth Y Karlan, Catherine J Kennedy, Lambertus A L M Kiemeney, Irene Konstantopoulou, Jolanta Kupryjanczyk, Yael Laitman, Ofer Lavie, Kate Lawrenson, Jenny Lester, Fabienne Lesueur, Carlos Lopez-Pleguezuelos, Phuong L Mai, Siranoush Manoukian, Taymaa May, Iain A McNeish, Usha Menon, Roger L Milne, Francesmary Modugno, Jennifer M Mongiovi, Marco Montagna, Kirsten B Moysich, Susan L Neuhausen, Finn C Nielsen, Catherine Noguès, Edit Oláh, Olufunmilayo I Olopade, Ana Osorio, Laura Papi, Harsh Pathak, Celeste L Pearce, Inge S Pedersen, Ana Peixoto, Tanja Pejovic, Pei-Chen Peng, Beth N Peshkin, Paolo Peterlongo, C Bethan Powell, Darya Prokofyeva, Miquel Angel Pujana, Paolo Radice, Muhammad U Rashid, Gad Rennert, George Richenberg, Dale P Sandler, Naoko Sasamoto, Veronica W Setiawan, Priyanka Sharma, Weiva Sieh, Christian F Singer, Katie Snape, Anna P Sokolenko, Penny Soucy, Melissa C Southey, Dominique Stoppa-Lyonnet, Rebecca Sutphen, Christian Sutter, Manuel R Teixeira, Kathryn L Terry, Liv Cecilie V Thomsen, Marc Tischkowitz, Amanda E Toland, Toon Van Gorp, Ana Vega, Digna R Velez Edwards, Penelope M Webb, Jeffrey N Weitzel, Nicolas Wentzensen, Alice S Whittemore, Stacey J Winham, Anna H Wu, Siddhartha Yadav, Yao Yu, Argyrios Ziogas, Andrew Berchuck, Fergus J Couch, Ellen L Goode, Marc T Goodman, Alvaro N Monteiro, Kenneth Offit, Susan J Ramus, Harvey A Risch, Joellen M Schildkraut, Mads Thomassen, Jacques Simard, Douglas F Easton, Michelle R Jones, Georgia Chenevix-Trench, Simon A Gayther, Antonis C Antoniou, and Paul D P Pharoah
The Journey to Improve the College of American Pathologists Cancer Biomarker Reporting Protocols., Brett Baskovich, Alexander Baras, Raja R Seethala, Patrick L Fitzgibbons, Frank Schneider, Brent T Harris, and Joseph Khoury
The impact of standardized robotics course training during colorectal surgery fellowship on post-training practice: a survey of graduates., Amir Bastawrous, Hannah Bossie, I-Fan Shih, Yanli Li, Mark Soliman, and Robert K Cleary
A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With Refractory Thoracic Tumors., Kathryn E Beckermann, Christine M Bestvina, Badi El Osta, Rachel E Sanborn, Hossein Borghaei, Philip Edward Lammers, Giovanni Selvaggi, Jennifer G Whisenant, Ellen Heimann-Nichols, Lynne Berry, Chih-Yuan Hsu, Yu Shyr, Leora Horn, and Heather Wakelee
Cancer Immunotherapy 102, R Brian Bell
From Dysplasia to Advanced Stage Oral Cancer: An Update on Diagnosis and Treatment, R Brian Bell
Updated results from a phase 1/2 study of HPN328, a tri-specific, half-life (T1/2) extended DLL3-targeting T-cell engaged in patients (pts) with small cell lung cancer (SCLC) and other neuroendocrine cancers (NEC), Himisha Beltran, Rachel E Sanborn, and See full list of authors in comments
Artificial intelligence VS human pathology, Carlo Bifulco
Decoding the Tumor Microenvironment with Spatial Biology and AI, Carlo Bifulco
Defining a Quality Specimen: Tissue Requirements and Quality Controls, Carlo Bifulco
Foundational Pathology Models to Drive Personalized Immunotherapies, Carlo Bifulco
Foundation Digital Pathology Models: From Computational Pathology to Spatial Biology, Carlo Bifulco
Other Pathologic Considerations, Carlo Bifulco
Beyond the hippocampus: Amygdala and memory functioning in older adults., Tess H Bookheimer, Aarthi S Ganapathi, Fatima Iqbal, Emily S Popa, Jenna Mattinson, Jennifer E Bramen, Susan Y Bookheimer, Verna R Porter, Mihae Kim, Ryan M Glatt, Austin W Bookheimer, David A Merrill, Stella E Panos, and Prabha Siddarth
Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study., Alexandra J Borst, Whitney Eng, Morgan Griffin, Kiersten W Ricci, Elissa Engel, Denise M Adams, Jillian Dayneka, Sally J Cohen-Cutler, Steven M Andreoli, Melinda D Wu, Allison P Wheeler, Kenneth M Heym, Shelley E Crary, Taizo A Nakano, Rachael R Schulte, Bhuvana A Setty, Thomas W McLean, Kristy S Pahl, Stefanos Intzes, Irina Pateva, Max Teitelbaum, Zili Zong, Yimei Li, and Michael R Jeng
Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy., Marcia S Brose, Jaume Capdevila, Rossella Elisei, Lars Bastholt, Dagmar Führer-Sakel, Sophie Leboulleux, Iwao Sugitani, Matthew H Taylor, Zhuoying Wang, Lori J Wirth, Francis P Worden, John Bernard, Paolo Caferra, Raffaella M Colzani, Shiguang Liu, and Martin Schlumberger
Adaptation of a Tailored Lung Cancer Screening Decision Aid for People With HIV., Meagan C Brown, Madison Snidarich, Jehan Z Budak, Nicholas Murphy, Nicholas Giustini, Perrin E Romine, Bryan J Weiner, Tanner Caverly, Kristina Crothers, and Matthew Triplette
Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial., Andrea J Bullock, Benjamin L Schlechter, Marwan G Fakih, Apostolia M Tsimberidou, Joseph E Grossman, Michael S Gordon, Breelyn A Wilky, Agustin Pimentel, Daruka Mahadevan, Ani S Balmanoukian, Rachel E Sanborn, Gary K Schwartz, Ghassan K Abou-Alfa, Neil H Segal, Bruno Bockorny, Justin C Moser, Sunil Sharma, Jaymin M Patel, Wei Wu, Dhan Chand, Katherine Rosenthal, Gabriel Mednick, Chloe Delepine, Tyler J Curiel, Justin Stebbing, Heinz-Josef Lenz, Steven J O'Day, and Anthony B El-Khoueiry
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma., Naresh Bumma, Joshua Richter, Sundar Jagannath, Hans C Lee, James E Hoffman, Attaya Suvannasankha, Jeffrey A Zonder, Mansi R Shah, Suzanne Lentzsch, Rachid Baz, Joseph J Maly, Swathi Namburi, Matthew J Pianko, Jing Christine Ye, Ka Lung Wu, Rebecca Silbermann, Chang-Ki Min, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquín Martínez-Lopez, Kaniel Cassady, Michelle DeVeaux, Dhruti Chokshi, Anita Boyapati, Anasuya Hazra, George D Yancopoulos, L Andres Sirulnik, Karen Rodriguez Lorenc, Glenn S Kroog, Yariv Houvras, and Madhav V Dhodapkar
Long-term follow up of E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group, Barbara Burtness and Richard Bryan Bell
Sunitinib in Patients With Breast Cancer With, Carmen J Calfa, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn, Monika L Burness, Keerthi Gogineni, Nitin Rohatgi, Tareq Al Baghdadi, Alison Conlin, Anu Gaba, Omid Hamid, Jairam Krishnamurthy, Naga Jyothi Gavini, Philip J Gold, Jordi Rodon, Jens Rueter, Ramya Thota, Gina N Grantham, Dominique C Hinshaw, Abigail Gregory, Susan Halabi, and Richard L Schilsky
Rinatabart Sesutecan For Patients With Heavily Pretreated Ovarian Or Endometrial Cancer: Results From The Dose Escalation Cohort Of A Phase 1/2 Study, Justin Call, Ian Anderson, and See full list of authors in comments
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With, Timothy L Cannon, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Vi K Chiu, Jimmy Hwang, Namrata Vijayvergia, Olatunji B Alese, Elie G Dib, Herbert L Duvivier, Kelsey A Klute, Vaibhav Sahai, Eugene R Ahn, Pablo Bedano, Deepti Behl, Sarah Sinclair, Ramya Thota, Walter Urba, Eddy S Yang, Gina N Grantham, Dominique C Hinshaw, Abigail Gregory, Susan Halabi, and Richard L Schilsky
A phase 1 dose escalation of pritumumab in patients with refractory or recurrent gliomas or brain metastases., Jose Carrillo, Jaya Mini Gill, Charles Redfern, Ivan Babic, Natsuko Nomura, Dhaval K Shah, Sean Carrick, and Santosh Kesari
Health disparities in cervical cancer: Estimating geographic variations of disease burden and association with key socioeconomic and demographic factors in the US., Tara Castellano, Andrew K ElHabr, Christina Washington, Jie Ting, Yitong J Zhang, Fernanda Musa, Ezgi Berksoy, Kathleen Moore, Leslie Randall, Jagpreet Chhatwal, Turgay Ayer, and Charles A Leath
Proton pump inhibitors are detrimental to overall survival of patients with glioblastoma: Results from a nationwide real-world evidence database., Michael P Castro, Jameson Quinn, Asher Wasserman, Alaa Awawda, Zachariah D Cole, Mark A Shapiro, Timothy J Stuhlmiller, and Santosh Kesari
Individualized Prediction for Risk of Recurrence in Stage I/II Melanoma Patients With Negative Sentinel Lymph Node., Shu-Ching Chang, Kristel Lourdault, Gary L Grunkemeier, Douglas Hanes, Shih-Ting Chiu, Stacey Stern, and Richard Essner
MRI-derived radiomics assessing tumor-infiltrating macrophages enable prediction of immune-phenotype, immunotherapy response and survival in glioma., Di Chen, Rui Zhang, Xiaoming Huang, Chunxia Ji, Wei Xia, Ying Qi, Xinyu Yang, Lishuang Lin, Jing Wang, Haixia Cheng, Weijun Tang, Jinhua Yu, Dave S B Hoon, Jun Zhang, Xin Gao, and Yu Yao
Acupuncture for Chronic Radiation-Induced Xerostomia in Head and Neck Cancer: A Multicenter Randomized Clinical Trial., Lorenzo Cohen, Suzanne C Danhauer, M Kay Garcia, Emily V Dressler, David I Rosenthal, Mark S Chambers, Andrew Cusimano, W Mark Brown, Jewel M Ochoa, Peiying Yang, Joseph S Chiang, Ora Gordon, Rhonda Crutcher, Jung K Kim, Michael P Russin, Joshua Lukenbill, Mercedes Porosnicu, Kathleen J Yost, Kathryn E Weaver, and Glenn J Lesser
Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer., Elizabeth Comen, Sadna Budhu, Yuval Elhanati, David B Page, Teresa Rasalan-Ho, Erika Ritter, Phillip Wong, George Plitas, Sujata Patil, Edi Brogi, Maxine Jochelson, Yolanda Bryce, Stephen B Solomon, Larry Norton, Taha Merghoub, and Heather L McArthur
